PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025

Market: Pharmaceuticals and Healthcare

Global, 419 pages report, published by GlobalData

Report ThumbnailNovember-2016
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025

Summary

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. F

Read More
  • 1.2 List of Figures
  • Figure 1: Influenza Virus Structure 30
  • Figure 2: 7MM, Cases with Seasonal Influenza Vaccination, All Ages, Both Sexes, N, 2015-2025 64
  • Figure 3: 7MM, Age-Specific Cases with Seasonal Influenza Vaccination, Both Sexes, N, 2015 66
  • Figure 4: 7MM, Sex-Specific Distribution of People Receiving Seasonal Influenza Vaccination, All Ages, N, 2015 68
  • Figure 5: 7MM, Seasonal Influenza Vaccination Rates, All Ages, Both Sexes, %, 2015-2025 70
  • Figure 6: 7MM, Age-Specific Seasonal Influenza
Read More
  • 1.1 List of Tables
  • Table 1: Notable Influenza Pandemics 33
  • Table 2: Influenza Symptoms 35
  • Table 3: Risk Factors and Comorbidities for Seasonal Influenza 38
  • Table 4: 7MM, Historical Perspective of Seasonal Influenza Vaccination Coverage 41
  • Table 5: 7MM, Sources of Epidemiological Data Used to Forecast Total Population Vaccination Rates of Seasonal Influenza 44
  • Table 6: 7MM, Sources of Epidemiological Data Used to Forecast Diagnosed Incident Cases of Outpatient Seasonal ILI 45
  • Table 7: 7MM, Source
Read More
  • 1 Table of Contents
  • 1 Table of Contents 10
  • 1.1 List of Tables 17
  • 1.2 List of Figures 24
  • 2 Introduction 26
  • 2.1 Catalyst 26
  • 2.2 Related Reports 27
  • 2.3 Upcoming Related Reports 27
  • 3 Disease Overview 28
  • 3.1 Etiology and Pathophysiology 28
  • 3.1.1 Etiology 28
  • 3.1.2 Pathophysiology 33
  • 3.1.3 Symptoms and Prognosis 34
  • 4 Epidemiology 36
  • 4.1 Disease Background 36
  • 4.2 Risk Factors and Comorbidities 38
  • 4.3 Global Trends 38
  • 4.3.1 Historical Perspective of Vaccination Coverage 39
  • 4.3.2 Laboratory Confirmed Infl
Read More
  • Seasonal influenza vaccines market will hit $4.3 billion by 2025, says GlobalData

    The seasonal influenza vaccine market across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will rise from $3.1 billion in 2015 to $4.3 billion by 2025, at a compound annual growth rate of 3.3%, according to research and consulting firm GlobalData.

    The company’s latest report states that the main growth drivers during the forecast period will include amendments to the n
Read More

Please select a license type

Share

Related Products

GlobalDataPharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025Product ThumbnailPharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025, Industry ReportProduct #: 631489
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved